Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Methylprednisolone Infusion in Early ARDS
NCT00562835Phase 3Unknown
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Feb 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection in acute respiratory distress syndrome (ARDS), acute lung injury (ALI), sponsored by Università Cattolica del Sacro Cuore. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
acute respiratory distress syndrome (ARDS)acute lung injury (ALI)
Beyond the preview
Go deeper on NCT00562835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562835.